Evidence map›Paper›PMID 28928852›Full record

ReviewJournal of Cancer2017

DCIS Margins and Breast Conservation: MD Anderson Cancer Center Multidisciplinary Practice Guidelines and Outcomes.

Henry M Kuerer, Benjamin D Smith, Mariana Chavez-MacGregor, Constance Albarracin, Carlos H Barcenas, Lumarie Santiago, Mary E Edgerton, Gaiane M Rauch, Sharon H Giordano, Aysegul Sahin and 5 more

Open access · goldAbstract readReview
In one paragraph

Review in Journal of Cancer, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 52 citations in OpenAlex.

  1. Trial
  2. Breast Cancer Screening After Gender-Affirming Chest Masculinization Surgery: The Overlooked Role of Mammography.Annals of surgery open : perspectives of surgical history, education, and clinical approaches · 2026
    Article
  3. Response to: Breast Cancer Screening After Gender-Affirming Chest Masculinization Surgery: The Overlooked Role of Mammography.Annals of surgery open : perspectives of surgical history, education, and clinical approaches · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. "Journal of personalized medicine · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. De-Escalation of Locoregional Therapy in Low-Risk Disease for DCIS and Early-Stage Invasive Cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2020
    Review
  19. Review
  20. Ductal carcinoma in situ of the breast: an update for the pathologist in the era of individualized risk assessment and tailored therapies.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Henry M KuererDepartment of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Benjamin D SmithDepartment of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Mariana Chavez-MacGregorDepartment of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Constance AlbarracinDepartment of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Carlos H BarcenasDepartment of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Lumarie SantiagoDepartment of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Mary E EdgertonDepartment of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Gaiane M RauchDepartment of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Sharon H GiordanoDepartment of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Aysegul SahinDepartment of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Savitri KrishnamurthyDepartment of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Wendy WoodwardDepartment of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Debasish TripathyDepartment of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Wei T YangDepartment of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Kelly K HuntDepartment of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
The University of Texas MD Anderson Cancer Center · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
NCI NIH HHS P30 CA016672
6 · The paper itself

Abstract

Recent published guidelines suggest that adequate margins for DCIS should be ≥ 2 mm after breast conserving surgery followed by radiotherapy (RT). Many groups now use this guideline as an absolute indication for additional surgery. This article describes detailed multidisciplinary practices including extensive preoperative/intraoperative pathologic/histologic image-guided assessment of margins, offering some patients with small low/intermediate grade DCIS no RT, the use/magnitude of radiation boost tailoring to margin width, and endocrine therapy for ER-positive DCIS. Use of these protocols over the past 20-years has resulted in 10-year local recurrence rates below 5% for patients with negative margins < 2 mm who received RT. Patients with margins < 2 mm who do not receive RT experience significantly higher local failure rates. Thus, there is not an absolute need to achieve wider negative surgical margins when < 2 mm for patients treated with RT and this should be determined by the multidisciplinary team. Utilization of these multidisciplinary treatment protocols and techniques may not be exportable and extrapolated to all hospitals, breast programs and systems as they can be complex and resource intensive.

Indexed as

breast cancerDCISductal carcinoma in situmargins.pathologyradiotherapysurgery

Identifiers

PMID28928852
PMCPMC5604195
OpenAlexW2755130092

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.